Literature DB >> 21952200

Beta-arrestin2 as a competitor for GRK2 interaction with the GLP-1 receptor upon receptor activation.

Rasmus Jorgensen1, Sarah Norklit Roed, Anders Heding, Christian E Elling.   

Abstract

The signaling of seven transmembrane receptors/G-protein- coupled receptors (GPCRs) is regulated by a number of receptor interacting proteins, including βarrestins (βarrs) and GPCR kinases (GRKs). In the present report, we have analyzed the interaction pattern between the glucagon-like peptide-1 (GLP-1) receptor (GLP-1R), βarr2, and GRK2 using bioluminescence resonance energy transfer assays. We found that βarr2 interacts with the GLP-1R in a biphasic manner with a phosphorylation-independent and a phosphorylation-dependent component. In competition experiments, we observed βarr2 competing with GRK2 for interaction with GLP-1R. We propose a model were βarr2 competes with GRK2 for interaction with the activated and GRK phosphorylated GLP-1R, suggesting a new role of βarr2 in regulating the orchestration of GRK2 functionality.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21952200     DOI: 10.1159/000330742

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  9 in total

Review 1.  Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes.

Authors:  Chris de Graaf; Dan Donnelly; Denise Wootten; Jesper Lau; Patrick M Sexton; Laurence J Miller; Jung-Mo Ahn; Jiayu Liao; Madeleine M Fletcher; Dehua Yang; Alastair J H Brown; Caihong Zhou; Jiejie Deng; Ming-Wei Wang
Journal:  Pharmacol Rev       Date:  2016-10       Impact factor: 25.468

2.  Functional consequences of glucagon-like peptide-1 receptor cross-talk and trafficking.

Authors:  Sarah Noerklit Roed; Anne Cathrine Nøhr; Pernille Wismann; Helle Iversen; Hans Bräuner-Osborne; Sanne Moeller Knudsen; Maria Waldhoer
Journal:  J Biol Chem       Date:  2014-12-01       Impact factor: 5.157

Review 3.  Beta-Arrestins in the Treatment of Heart Failure Related to Hypertension: A Comprehensive Review.

Authors:  Ahmed Rakib; Taslima Akter Eva; Saad Ahmed Sami; Saikat Mitra; Iqbal Hossain Nafiz; Ayan Das; Abu Montakim Tareq; Firzan Nainu; Kuldeep Dhama; Talha Bin Emran; Jesus Simal-Gandara
Journal:  Pharmaceutics       Date:  2021-06-05       Impact factor: 6.321

4.  GRK2 regulates GLP-1R-mediated early phase insulin secretion in vivo.

Authors:  Alba C Arcones; Rocío Vila-Bedmar; Mercedes Mirasierra; Marta Cruces-Sande; Mario Vallejo; Ben Jones; Alejandra Tomas; Federico Mayor; Cristina Murga
Journal:  BMC Biol       Date:  2021-03-03       Impact factor: 7.431

Review 5.  Hypothalamic GPCR Signaling Pathways in Cardiometabolic Control.

Authors:  Yue Deng; Guorui Deng; Justin L Grobe; Huxing Cui
Journal:  Front Physiol       Date:  2021-06-28       Impact factor: 4.566

6.  BRET biosensors to study GPCR biology, pharmacology, and signal transduction.

Authors:  Ali Salahpour; Stefano Espinoza; Bernard Masri; Vincent Lam; Larry S Barak; Raul R Gainetdinov
Journal:  Front Endocrinol (Lausanne)       Date:  2012-08-29       Impact factor: 5.555

7.  Co-expression of GRK2 reveals a novel conformational state of the µ-opioid receptor.

Authors:  Sarah A Nickolls; Sian Humphreys; Mellissa Clark; Gordon McMurray
Journal:  PLoS One       Date:  2013-12-20       Impact factor: 3.240

8.  GRK Inhibition Potentiates Glucagon-Like Peptide-1 Action.

Authors:  Seunghun P Lee; Jenson Qi; Guozhang Xu; Matthew M Rankin; James Littrell; June Zhi Xu; Ivona Bakaj; Alessandro Pocai
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-14       Impact factor: 5.555

9.  The GIP receptor displays higher basal activity than the GLP-1 receptor but does not recruit GRK2 or arrestin3 effectively.

Authors:  Suleiman Al-Sabah; Munya Al-Fulaij; Ghina Shaaban; Hanadi A Ahmed; Rosalind J Mann; Dan Donnelly; Moritz Bünemann; Cornelius Krasel
Journal:  PLoS One       Date:  2014-09-05       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.